Founded in 2002, NDI is headquartered in Cleveland, Ohio with locations in North Carolina’s Research Triangle and Minneapolis, Minnesota. NDI has a proven track record of moving technologies from innovation to commercialization. In April 2008, NDI sold its first portfolio company to Medtronic Inc. for $42 million, returning over 150 times the original investment back to investors.

NDI is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies that are intended to restore lost neurological function, prevent damage and reduce the painful effects of disease and injury.

NDI provides the capital to:
Identify and develop technologies

Launch and grow companies
Take them to successful exits

ABOUT NDI HEALTHCARE FUND

Since 2008, the NDI Healthcare Fund and its portfolio companies have raised $26 million, including $17 million in private equity and another $9 million in grants and loans from sources such as the National Institutes of Health, U.S. Department of Defense, and the State of Ohio’s Third Frontier Program. These funds are used to develop opportunities exclusively in neurotechnology that address unmet needs and have the potential to provide significant returns to investors.

ABOUT NDI MEDICAL, LLC

NDI Medical greatly reduces the investment of time and capital required to incubate and launch new products and therapies, taking ideas from innovation to exit in the most efficient manner possible by uniquely leveraging:

Checkpoint - Nerve Stimulator & Locator Device - Brochure

Contact supplier